identification vaccine candidates serogroup b meningococcus whole-genome sequencing 
neisseria meningitidis major cause bacterial septicemia meningitis sequence variation surface-exposed proteins cross-reactivity serogroup b capsular polysaccharide human tissues hampered efforts develop successful vaccine overcome obstacles entire genome sequence bf virulent serogroup b strain mc58 used identify vaccine candidates total candidate antigens expressed escherichia coli purified used immunize mice sera allowed identification proteins surface exposed conserved sequence across range strains induce bactericidal antibody response property known correlate vaccine efficacy humans 
